Research Tracker›Biomarker Atlas›Gulf War Illness›Interleukin-1β (IL-1β)

Interleukin-1β (IL-1β) in Gulf War Illness

Interleukin-1β (IL-1β), also described as Pro-inflammatory cytokine, belongs to the inflammatory group of Gulf War Illness (GWI, Gulf War Syndrome) markers and is reported to be raised relative to healthy Gulf War veteran controls. The cited literature links this alteration to pain, neuroinflammation. This entry summarises Johnson et al. 2016. Group-level associations like this do not translate into an individual diagnostic cut-off.

↑ ElevatedInflammatoryLOINC 13629-1

Summary

Direction in Gulf War Illness↑ Elevated — higher than in the comparison group
CategoryInflammatory
Also described asPro-inflammatory cytokine
Compared againstHGV (healthy Gulf War veteran controls)
Associated symptomsPain, neuroinflammation
Test typeBlood test (serum / plasma / whole blood)
LOINC code13629-1
SourceJohnson et al. 2016 — doi:10.1371/journal.pone.0157855
Condition atlasGulf War Illness Biomarker Atlas

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Measurement of biomarkers of inflammatory immune response. (3 registered trials use a matching outcome measure).

Clinical trials using Interleukin-1β (IL-1β) as an outcome

NCT06294756Completed
Sulfureous Water Therapy in Viral Respiratory Diseases
Outcome measure: To assess if H2S present in STW can interfere with concentration of inflammatory markers ( as IL1B, IL-6, ACE, S100B, GSS, Hs-CRP) typically alterated in long covid patients.
NCT05128292Completed
Effect of CoQ10 Plus Selenium Supplementation on Clinical Outcomes and Biochemical Markers in ME/CFS (CoSeME Study)
Outcome measure: Measurement of biomarkers of inflammatory immune response.
NCT01650636Completed
Patient-Partner Stress Management Effects on Chronic Fatigue Syndrome Symptoms and Neuroimmune Process
Outcome measure: Changes in Neuroimmune Regulation Measured by Ratio of Pro-Inflammatory to Anti-Inflammatory Cytokines

Interventions studied alongside this marker

Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.

Commercial test availability

Interleukin-1β (IL-1β), Serum — specialty laboratory test. Specialty cytokine test; not all sites offer standalone IL-1β.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Related Inflammatory markers in Gulf War Illness

Full list: Gulf War Illness Biomarker Atlas.

Frequently asked questions

Is Interleukin-1β (IL-1β) high or low in Gulf War Illness?

Elevated. Studies summarised in the OSMF atlas report higher Interleukin-1β (IL-1β) in Gulf War Illness than in healthy Gulf War veteran controls. Source: Johnson et al. 2016.

What symptoms is Interleukin-1β (IL-1β) associated with in Gulf War Illness?

The cited literature associates this marker with Pain, neuroinflammation. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Interleukin-1β (IL-1β)?

It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 13629-1. Commercial laboratories such as Quest Diagnostics, ARUP Laboratories list an orderable assay.

Is one abnormal Interleukin-1β (IL-1β) result diagnostic of Gulf War Illness?

No. No single biomarker is diagnostic of Gulf War Illness. Interleukin-1β (IL-1β) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Interleukin-1β (IL-1β) in Gulf War Illness: direction, evidence and what it means. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/gulf-war-illness/interleukin-1beta-il-1beta.html

Last reviewed: 2026-06-29 · Page generated from gulf-war-illness.json · Browse: Gulf War Illness atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.